These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 1374097)

  • 1. Cytotoxic T lymphocytes from HIV-1 seropositive individuals recognize immunodominant epitopes in Gp160 and reverse transcriptase.
    Lieberman J; Fabry JA; Kuo MC; Earl P; Moss B; Skolnik PR
    J Immunol; 1992 May; 148(9):2738-47. PubMed ID: 1374097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytotoxic T cell repertoire selection. A single amino acid determines alternative class I restriction.
    Bergmann CC; Tong L; Cua RV; Sensintaffar JL; Stohlman SA
    J Immunol; 1994 Jun; 152(12):5603-12. PubMed ID: 7515908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Broad recognition of cytotoxic T cell epitopes from the HIV-1 envelope protein with multiple class I histocompatibility molecules.
    Shirai M; Pendleton CD; Berzofsky JA
    J Immunol; 1992 Mar; 148(6):1657-67. PubMed ID: 1371784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A vaccinia-gp160-based vaccine but not a gp160 protein vaccine elicits anti-gp160 cytotoxic T lymphocytes in some HIV-1 seronegative vaccinees.
    Perales MA; Schwartz DH; Fabry JA; Lieberman J
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Sep; 10(1):27-35. PubMed ID: 7648281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An endogenously synthesized decamer peptide efficiently primes cytotoxic T cells specific for the HIV-1 envelope glycoprotein.
    Bergmann C; Stohlmann SA; McMillan M
    Eur J Immunol; 1993 Nov; 23(11):2777-81. PubMed ID: 7693478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preferential V beta usage by cytotoxic T cells cross-reactive between two epitopes of HIV-1 gp160 and degenerate in class I MHC restriction.
    Shirai M; Vacchio MS; Hodes RJ; Berzofsky JA
    J Immunol; 1993 Aug; 151(4):2283-95. PubMed ID: 7688397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of a primary human cytotoxic T-lymphocyte response against a novel conserved epitope in a functional sequence of HIV-1 reverse transcriptase.
    van der Burg SH; Klein MR; van de Velde CJ; Kast WM; Miedema F; Melief CJ
    AIDS; 1995 Feb; 9(2):121-7. PubMed ID: 7536421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of a vigorous HIV-1-specific cytotoxic T lymphocyte response in cerebrospinal fluid from infected persons with AIDS dementia complex.
    Jassoy C; Johnson RP; Navia BA; Worth J; Walker BD
    J Immunol; 1992 Nov; 149(9):3113-9. PubMed ID: 1383338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunization of mice with lipopeptides bypasses the prerequisite for adjuvant. Immune response of BALB/c mice to human immunodeficiency virus envelope glycoprotein.
    Martinon F; Gras-Masse H; Boutillon C; Chirat F; Deprez B; Guillet JG; Gomard E; Tartar A; Levy JP
    J Immunol; 1992 Nov; 149(10):3416-22. PubMed ID: 1385524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recognition of a small number of diverse epitopes dominates the cytotoxic T lymphocytes response to HIV type 1 in an infected individual.
    Lieberman J; Fabry JA; Fong DM; Parkerson GR
    AIDS Res Hum Retroviruses; 1997 Mar; 13(5):383-92. PubMed ID: 9075479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An HIV-1 envelope protein vaccine elicits a functionally complex human CD4+ T cell response that includes cytolytic T lymphocytes.
    Stanhope PE; Liu AY; Pavlat W; Pitha PM; Clements ML; Siliciano RF
    J Immunol; 1993 May; 150(10):4672-86. PubMed ID: 8097759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytolytic T lymphocytes (CTLs) from HIV-1 subtype C-infected Indian patients recognize CTL epitopes from a conserved immunodominant region of HIV-1 Gag and Nef.
    Thakar MR; Bhonge LS; Lakhashe SK; Shankarkumar U; Sane SS; Kulkarni SS; Mahajan BA; Paranjape RS
    J Infect Dis; 2005 Sep; 192(5):749-59. PubMed ID: 16088824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-1 reverse transcriptase-specific CTL against conserved epitopes do not protect against progression to AIDS.
    van der Burg SH; Klein MR; Pontesilli O; Holwerda AM; Drijfhout JW; Kast WM; Miedema F; Melief CJ
    J Immunol; 1997 Oct; 159(7):3648-54. PubMed ID: 9317165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three regions of HIV-1 gp160 contain clusters of immunodominant CTL epitopes.
    Shankar P; Fabry JA; Fong DM; Lieberman J
    Immunol Lett; 1996 Aug; 52(1):23-30. PubMed ID: 8877415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of a major histocompatibility complex class I-restricted cytotoxic T-lymphocyte response to a highly conserved region of human immunodeficiency virus type 1 (HIV-1) gp120 in seronegative humans immunized with a candidate HIV-1 vaccine.
    Johnson RP; Hammond SA; Trocha A; Siliciano RF; Walker BD
    J Virol; 1994 May; 68(5):3145-53. PubMed ID: 7908700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of primary cytotoxic T lymphocytes specific for the envelope glycoprotein of HIV-1 by deletion of the env amino-terminal signal sequence.
    McChesney M; Tanneau F; Regnault A; Sansonetti P; Montagnier L; Kieny MP; Rivière Y
    Eur J Immunol; 1990 Jan; 20(1):215-20. PubMed ID: 2106442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV-1 soluble antigens induced CD8+ cytotoxic T-cell responses in an immunized individual.
    Achour A; Moukrim Z; Picard O; Bizzini B; Burny A; Zagury D
    Cell Mol Biol (Noisy-le-grand); 1995 May; 41(3):395-400. PubMed ID: 7580833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytotoxic T lymphocytes in asymptomatic long-term nonprogressing HIV-1 infection. Breadth and specificity of the response and relation to in vivo viral quasispecies in a person with prolonged infection and low viral load.
    Harrer T; Harrer E; Kalams SA; Barbosa P; Trocha A; Johnson RP; Elbeik T; Feinberg MB; Buchbinder SP; Walker BD
    J Immunol; 1996 Apr; 156(7):2616-23. PubMed ID: 8786327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human immunodeficiency virus-1 reverse transcriptase immunodominant CD4+ T cell epitopes: a peptide-based multiparametric assessment in the mouse.
    Borg JP; Ihlenfeldt HG; Jung G; Haas G; Pierres M
    Eur J Immunol; 1994 Jul; 24(7):1496-502. PubMed ID: 7517871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Helper-cytotoxic T lymphocyte (CTL) determinant linkage required for priming of anti-HIV CD8+ CTL in vivo with peptide vaccine constructs.
    Shirai M; Pendleton CD; Ahlers J; Takeshita T; Newman M; Berzofsky JA
    J Immunol; 1994 Jan; 152(2):549-56. PubMed ID: 8283036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.